These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11932375)

  • 1. Percutaneous gadolinium injection under MR guidance to mark target for CT-guided radiofrequency ablation.
    Solomon SB; Bohlman ME; Choti MA
    J Vasc Interv Radiol; 2002 Apr; 13(4):419-21. PubMed ID: 11932375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation of liver dome hepatocellular carcinoma invisible on ultrasonography: a new targeting strategy.
    Lee MW; Kim YJ; Park SW; Jeon HJ; Yi JG; Choe WH; Kwon SY; Lee CH
    Br J Radiol; 2008 May; 81(965):e130-4. PubMed ID: 18440934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance guidance for radiofrequency ablation of liver tumors.
    Clasen S; Pereira PL
    J Magn Reson Imaging; 2008 Feb; 27(2):421-33. PubMed ID: 18219677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Between CT and MR Images as More Favorable Reference Data Sets for Fusion Imaging-Guided Radiofrequency Ablation or Biopsy of Hepatic Lesions: A Prospective Study with Focus on Patient's Respiration.
    Cha DI; Lee MW; Kang TW; Oh YT; Jeong JY; Chang JW; Ryu J; Lee KJ; Kim J; Bang WC; Shin DK; Choi SJ; Koh D; Kim K
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1567-1575. PubMed ID: 28462444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy.
    Liu CH; Yu CY; Chang WC; Dai MS; Hsiao CW; Chou YC; Huang GS
    J Chin Med Assoc; 2016 Feb; 79(2):93-100. PubMed ID: 26507775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
    Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR features after radiofrequency ablation (RFA).
    Cazejust J
    Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):81-2. PubMed ID: 21809482
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
    Mahnken AH; Buecker A; Spuentrup E; Krombach GA; Henzler D; Günther RW; Tacke J
    J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: preliminary results.
    Dong Y; Wang WP; Gan YH; Huang BJ; Ding H
    Clin Radiol; 2014 Nov; 69(11):1129-35. PubMed ID: 25060936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system].
    Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of the liver: how do we do it.
    Vandenbroucke F; Ilsen B; Craggs B; Op de Beeck B; de Mey J
    JBR-BTR; 2007; 90(6):490-1. PubMed ID: 18376762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
    Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.